Tectonic Therapeutic, Inc.
TECX
$27.96
$0.441.60%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 9.87% | 23.39% | 44.35% | 92.93% | 141.70% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 46.87% | 44.85% | 43.28% | 69.24% | 47.02% |
| Operating Income | -46.87% | -44.85% | -43.28% | -69.24% | -47.02% |
| Income Before Tax | -40.21% | -25.76% | -24.02% | -41.88% | -34.56% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -42.30% | -27.89% | -25.84% | -44.01% | -34.56% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -42.30% | -27.89% | -25.84% | -44.01% | -34.56% |
| EBIT | -46.87% | -44.85% | -43.28% | -69.24% | -47.02% |
| EBITDA | -48.61% | -46.63% | -44.46% | -71.21% | -48.38% |
| EPS Basic | 38.97% | 76.71% | 82.81% | 86.00% | 77.85% |
| Normalized Basic EPS | 39.87% | 77.09% | 83.04% | 86.18% | 77.85% |
| EPS Diluted | 38.97% | 76.71% | 82.81% | 86.00% | 77.85% |
| Normalized Diluted EPS | 39.87% | 77.09% | 83.04% | 86.18% | 77.85% |
| Average Basic Shares Outstanding | 50.97% | 116.59% | 240.37% | 838.65% | 840.80% |
| Average Diluted Shares Outstanding | 50.97% | 116.59% | 240.37% | 838.65% | 840.80% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |